Growth hormone/IGF-I and/or resistive exercise maintains myonuclear number in hindlimb unweighted muscles

J Appl Physiol (1985). 1997 Dec;83(6):1857-61. doi: 10.1152/jappl.1997.83.6.1857.

Abstract

In the present study of rats, we examined the role, during 2 wk of hindlimb suspension, of growth hormone/insulin-like growth factor I (GH/IGF-I) administration and/or brief bouts of resistance exercise in ameliorating the loss of myonuclei in fibers of the soleus muscle that express type I myosin heavy chain. Hindlimb suspension resulted in a significant decrease in mean soleus wet weight that was attenuated either by exercise alone or by exercise plus GH/IGF-I treatment but was not attenuated by hormonal treatment alone. Both mean myonuclear number and mean fiber cross-sectional area (CSA) of fibers expressing type I myosin heavy chain decreased after 2 wk of suspension compared with control (134 vs. 162 myonuclei/mm and 917 vs. 2,076 micron2, respectively). Neither GH/IGF-I treatment nor exercise alone affected myonuclear number or fiber CSA, but the combination of exercise and growth-factor treatment attenuated the decrease in both variables. A significant correlation was found between mean myonuclear number and mean CSA across all groups. Thus GH/IGF-I administration and brief bouts of muscle loading had an interactive effect in attenuating the loss of myonuclei induced by chronic unloading.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Count / drug effects
  • Cell Nucleus / ultrastructure
  • Cytoplasm / ultrastructure
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Growth Hormone / pharmacology*
  • Hindlimb / physiology*
  • Hindlimb Suspension
  • Insulin-Like Growth Factor I / pharmacology*
  • Microscopy, Confocal
  • Muscle, Skeletal / cytology
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / physiology*
  • Organ Size
  • Physical Conditioning, Animal / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology

Substances

  • Recombinant Proteins
  • Insulin-Like Growth Factor I
  • Growth Hormone